MERCK SHARP & DOHME CORP recalls Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp.,…

Recall date

October 19, 2021

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0093-2022

FDA classification

Class I

Brand / firm

MERCK SHARP & DOHME CORP

Sold / distributed

Nationwide within the United States

Why it was recalled

Presence of Particulate Matter: Identified as Glass Particles

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01